Over the last 10 years, we’ve successfully built an innovative culture that encourages scientific risk-taking within the bounds of our data-driven philosophy. This enables our agile R&D team to discover numerous preclinical candidates cost effectively. From these candidates, we select what we believe are highly differentiated programs for clinical development.
From the outset, we’ve sought out ways to improve upon the current model—both in terms of how we operate and the proven discoveries we build upon. Our pioneering team is the powerhouse behind our proprietary technology and the culture at Inhibrx.Meet our team